Adial Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|
Revenue | $0 | $0 | $32 |
Gross Profit | |||
EBITDA | -2,211 | -2,287 | -1,844 |
EBIT | -2,211 | -2,287 | -1,845 |
Net Income | -2,191 | -2,458 | -6,476 |
Net Change In Cash | 0 | 0 | 32 |
Free Cash Flow | -1,694 | -2,148 | -1,626 |
Cash | 5,204 | 3,288 | 5,025 |
Basic Shares | 5,835 | 4,182 | 2,953 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -60 | -55 | ||
EBITDA | -7,001 | -13,317 | -19,462 | -10,927 |
EBIT | -7,001 | -13,317 | -19,517 | -10,927 |
Net Income | -7,001 | -12,731 | -19,423 | -10,860 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -2,375 | |||
Free Cash Flow | -6,806 | -11,185 | -12,014 | -7,633 |
Cash | 2,827 | 4,001 | 6,062 | 4,401 |
Basic Shares | 1,424 | 1,063 | 743 | 498 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.38 |
2024-06-30 | -$0.59 |
2024-03-31 | -$0.62 |
2023-12-31 | -$1.35 |
